S1D), bone metastatic samples presented high expression of BTN3A1 in most of the cores, with the majority of cancer cells (≥50%) staining positively for BTN3A1 expression in 63% of the cores analyzed (Fig. 1E). The gene discussed is BTN3A1; the disease is cancer.